Investment Q&A

Q: Doing a year end review of all of my holdings. I would like to reduce my position in several stocks (or eliminate entirely in the case of HR.UN and CPH) in order to raise some cash for increasing my position in several other holdings. Fairly large question, so I will divide it into 2, this for the potential reductions and a further question about the potential adds. Would you please rank these stocks in the order you would reduce or eliminate to raise some cash, starting with the one you would be most inclined to reduce/eliminate. Sector, or large cap/small cap not a concern, as I have a broadly diversified portfolio with a lot (too many, really) of names. Thank you for this, and also for the very good service. My 1st year as a client, and I will certainly be renewing. I have recommended the site to a few friends who also do investing.

Q: Trying to reduce the number of stocks I hold. Currently I am broadly diversified across sectors and large cap/small cap, growth/dividend payers, so those are not concerns. I look at total return, and have a long term horizon, 5+ years. Comfortable with risky stocks. I have smallish positions in these 12 stocks and would like to sell maybe 6 to 8 of them, and redeploy the money into a few of the others on the list or into some of my other holdings. Would you select 6 - 8 of the above that you think are less likely to perform well over 5+ years, and could be sold, and maybe 2 - 4 that could be added to. Thank you.

Q: Thanks for your ongoing non-biased advice.
I have three DOGS in my non registered account ...... Baylin Technologies (BYL) with No Dividend, Cipher Pharma (CPH) with No Dividend and Pason Systems (PSI) that has a 3.5% Dividend.
Please analyze each account for future growth prospects, survivability etc.
My strategy is to double-down and buy more of each stock in my wife's non registered account during tax loss season because her income is very low ......... then wait 30 days and sell the above stocks after 30 days in my registered account either this year or next year.
Hope this strategy makes
MMD

Q: I would like to know what you think of their recent Q, do you see anything to suggest that the higher EPS and revs will continue here or is this a one off gain?

Q: CPH took it on the chin yesterday with Bauch Health pulling out of an agreement. Trying to find out the impact of this event to the company. Information seems to be hard to find.

Q: I would like to sell subject 4 companies, unless your advice is to hold because of much near term growth potential.
Please suggest 5 each U.S. and Canadian companies that you consider offering the
' best ' growth, short and medium term, with no consideration of industry.
Thanks
Klaus

Q: It looks like this company should be quite profitable after taking all the one time impairment charges in this latest quarter. What do you think of it moving forward as a value play.

Q: CPH just released Q results, do you see things turning around? They have more cash and less debt than last quarter and they continue to make a profit - please evaluate these metrics. Finally, would you comment on the initiatives outlined in the strategic update?

Q: I was watching James Hodgins on Market Call last week and he mentioned that he is "restricted on the name and cant talk about it too much". What can be possible reasons for this? Thank you.

Q: Cipher's quarterly report highlights transitions and strategic positioning for long term growth, also debt reduction. Their list of 2018 year end highlights appears impressive but does it read that way to you? This company looks busy for their size but what significants do you take from the list of 2019 anticipated milestones? Would you dip a toe in here? Finally how similar are CPH and GUD in strategic growth plans?

Q: Opinion of value after last report, and responding share price movement?

Q: May I have your opinion? It seems rather beat down. Possibility of GUD.TO taking them out?

Q: Cipher, is hosting an investor webcast today, I am hoping you can report and summarize this event. The question for me regarding this co. is are they growing and I am looking for proof of traction not only in revs but also profits.

Q: I was wondering your opinion about Cypher Pharmaceuticals and Centric Health Care. Would you buy either of these and could you give an explanation, thanks
Mary

Q: CPH has been really beaten up lately. What do you think is the reason.
Do you view this as a good buying opportunity?
Do you think that GUD is interested in this company?
...........thank you

Q: CPH has showed some recent strength lately. That being said, is it time to switch out of the name and take advantage of the price pull back that COV is experiencing?

Q: I am holding a position in this company waiting to see what the acquisition of Cardiome Pharma will look like - meaning will this put CPH on a path to higher earning. However the stock price is finding new 52 week lows. Would your advice be sell now or give them a quarter or two to see what this acquisition is going to look like?

Q: Can please give some update after the company has sold its US operations? Will this step will help company to focus on its Canadian operation?
Thanks

Q: Can you please comment on the acquisition made today? After lots of acquisitions should this not finally alleviate growth concerns?

Also, from Cardiome's recent investor presentation it looks like they had Canadian tax credits of 190M cad @ 26% = $49M (versus the company's 75M total tax credits). I am assuming that is what "NOL CFWDs" means? From the news release it appears Cipher may get these credits in the transaction. That seems very beneficial for Cipher as they would be in a position to actually use them immediately where Cardiome operating at a loss could not. Is my thinking correct here?

Thanks!

Q: Do you like the acquisition that CPH made today? How safe is it to buy shares at this, 52 week low? Does the potential look good to you?